| Neptune Progresses in its European Market Penetration of Neptune Krill Oil |
| Tuesday, November 29 2005 | |||
Neptune Progresses in its European Market Penetration of Neptune Krill OilLaval Quebec CANADA, November 29, 2005 - Neptune Technologies and Bioressources (NTB: TSX-V) is pleased to announce that Neptune Krill Oil and its Logo and Trademark have been approved and registered by the European Registration Office. The “Direction Départementale de la Concurrence, de la Consommation et de la Répression des Fraudes” (DDCCRF) analyzed NKO™, under the Neptune Trademark – “Polar Oil”, and found that it completely conforms to their requirements. Tina Sampalis M.D., Ph.D., Vice-President, Research/Business Development for Neptune Technologies & Bioressources Inc, states “these approvals open the European market for Neptune’s product – NKO™; this adds 860,000,000 potential consumers to Neptune’s target market.” The Neptune team is presently attending the “Food Ingredients Trade Show– Europe”, in Paris (Nov.29 – Dec.01) in order to introduce Neptune products in Europe and to meet with potential strategic partners already showing interest in NKO™. This press release is available on the Company's on-line Investor Relations site for investor commentary, feedback and questions. Investors are invited to visit http://www.agoracom.com/ and select the Neptune Technologies Information and Contact Forum, or link directly to it at http://www.agoracom.com/nonmemforum/main.asp?topic=neptune+technologies&tr; Investors are also invited to e-mail any questions regarding the Company directly to This e-mail address is being protected from spambots, you need JavaScript enabled to view it Potential investors may also use this address to request being added to the Neptune Technologies investor e-mail list. Neptune Technologies & Bioressources Inc. https://www.neptunebiotech.com/ FORWARD-LOOKING STATEMENTS: Neptune Technologies and Acasti Pharma Contact:
Neptune Technologies & Bioressources Inc. Acasti Pharma Inc. Toni Rinow, Ph.D., MBA Corporate Development & Investor Relations (450) 687-2262 This e-mail address is being protected from spambots, you need JavaScript enabled to view it
|